Picture of Insmed logo

INSM Insmed Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapMomentum Trap

Annual cashflow statement for Insmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-254-294-435-482-750
Depreciation
Amortisation
Non-Cash Items56.162.511562.2239
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-63-2.95-58.66.58-39.2
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-251-219-363-400-536
Capital Expenditures-42.3-6.82-7.29-9.88-13.3
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-57-24.7-210
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-42.3-6.82-64.3-34.6-224
Financing Cash Flow Items4.50-16.8-18.4-1.22
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities285271613793168
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-7.6445.3184357-592